Evidence map›Paper›PMID 28402033›Full record

Observational studyEarly intervention in psychiatry2018

Metabolic syndrome in antipsychotic naive African patients with severe mental illness in usual care.

Shamima Saloojee, Jonathan K Burns, Ayesha A Motala

Abstract readObservational Study
In one paragraph

Observational study in Early intervention in psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 3 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. A follow-up study of metabolic syndrome in schizophrenia.European archives of psychiatry and clinical neuroscience · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Shamima SaloojeeDepartment of Psychiatry, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Jonathan K BurnsDepartment of Psychiatry, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Ayesha A MotalaDepartment of Diabetes and Endocrinology, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
University of KwaZulu-Natal · ZA

Funding

ENHANCING, TRAINING, RESEARCH CAPACITY AND EXPERTISE IN HIV CARE-ENTREER24TW008863 · FIC · UNIVERSITY OF KWAZULU-NATAL · PI BOBAT, RAZIYA, HAMMER, SCOTT M · 2010 to 2015
$8.6M
FIC NIH HHS R24 TW008863NIH HHS
6 · The paper itself

Abstract

backgroundTo determine the prevalence and incidence of metabolic syndrome in individuals with a first episode of severe mental illness from South Africa.

methodsAntipsychotic naïve study subjects with a first episode of severe mental illness and control subjects were recruited at baseline for a prospective study. Individuals without metabolic syndrome at baseline were followed up for 12 months after antipsychotic medication was initiated. Metabolic syndrome was determined at baseline and at the 12-month follow-up using the Joint Interim Statement criteria.

resultsAt baseline, the 67 study (M:F; 48:19) and 67 control subjects (M:F; 48:19) had a mean age of 22.8 (±3.7) and 23.3 (±2.6) years (P = .4), respectively. The majority were of black African ethnicity (97%) and 82% were diagnosed with schizophrenia. There was no difference in the prevalence of metabolic syndrome (4.5%) or any of the individual components between the study and control group prior to the initiation of antipsychotics. Of the 64 study subjects without metabolic syndrome at baseline, only 36 (M:F; 25:11) completed the 12-month follow-up (response rate 56.3%) and 2 subjects developed metabolic syndrome .The incidence of metabolic syndrome was 5.5% with a significant increase in the elevated waist circumference criterion after 1 year of antipsychotic treatment (P = .02).

conclusionsThere was a low prevalence and incidence of metabolic syndrome in this group of patients with a first episode of severe mental illness.

Indexed as

AdolescentAdultAntipsychotic AgentsBipolar DisorderCase-Control StudiesComorbidityFemaleHumansIncidenceMaleMetabolic SyndromePrevalenceProspective StudiesPsychotic DisordersSchizophreniaSouth AfricaAntipsychotic Agentsantipsychotic agentsmetabolic syndrome XSouth Africa

Identifiers

PMID28402033
PMCPMC5638667
OpenAlexW2607374586

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.